SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Nymox Pharmaceutical Corp – ‘20-F’ for 12/31/03 – EX-99.8

On:  Wednesday, 6/30/04, at 2:00pm ET   ·   For:  12/31/03   ·   Accession #:  897069-4-1263   ·   File #:  1-12033

Previous ‘20-F’:  ‘20-F/A’ on 6/19/03 for 12/31/02   ·   Next:  ‘20-F’ on 6/30/05 for 12/31/04   ·   Latest:  ‘20-F’ on 5/2/23 for 12/31/22   ·   3 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 6/30/04  Nymox Pharmaceutical Corp         20-F       12/31/03    7:1.1M                                   Foley & Lardner/FA

Annual Report of a Foreign Private Issuer   —   Form 20-F
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 20-F        Annual Report                                       HTML    928K 
 3: EX-99.11    Code of Conduct                                     HTML    165K 
 4: EX-99.12(A)  Miscellaneous Exhibit                              HTML     11K 
 5: EX-99.12(B)  Miscellaneous Exhibit                              HTML     11K 
 6: EX-99.13(A)  Miscellaneous Exhibit                              HTML      6K 
 7: EX-99.13(B)  Miscellaneous Exhibit                              HTML      6K 
 2: EX-99.8     List of Subsidiaries                                HTML      4K 


EX-99.8   —   List of Subsidiaries


This exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



Exhibit 8

SUBSIDIARIES OF NYMOX PHARMACEUTICAL CORPORATION

Serex, Inc., a New Jersey corporation.

Nymox Corporation, a Delaware corporation.


3 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/02/23  Nymox Pharmaceutical Corp.        20-F       12/31/22  105:5.5M                                   Pubco Reporting … Inc/FA
 3/30/22  Nymox Pharmaceutical Corp.        20-F       12/31/21  106:6M                                     Pubco Reporting … Inc/FA
 3/29/21  Nymox Pharmaceutical Corp.        20-F       12/31/20  103:4.4M                                   Pubco Reporting … Inc/FA
Top
Filing Submission 0000897069-04-001263   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Mar. 29, 2:50:04.1am ET